Slim Weight Loss Clinic（Palm Beach Gardens, FL）
常见问题
How long before Semaglutide starts to work?
Patients who use Semaglutide for weight loss typically begin seeing results after the first four weeks of treatment.
Is Semaglutide approved for weight loss?
Yes, Semaglutide is FDA approved as a safe and effective treatment for weight management and obesity.
What is the difference between Saxenda and Semaglutide?
Although both Saxenda (Liraglutide) and Semaglutide are GLP-1 agonists that mimic the glucagon-like peptide, Semaglutide is more effective at improving blood glucose levels and achieving weight loss than Saxenda. In terms of convenience, Semaglutide is also more tolerable as a once-a-week injection, whereas Saxenda injections require daily injections.
What if I miss a dose?
If you miss administering a dose of Semaglutide, you should take it as soon as you remember. If the time frame is too close to your next dose, you should skip the missed dose altogether and resume your normal dosing schedule to avoid double dosing.
Can the drug improve overall health?
Yes. By improving weight loss, Semaglutide can also help improve cardiovascular, physical, and mental health, which leads to improved overall health.
How long does it take to lose weight on Semaglutide?
That will depend on your body type and the level of treatment. However, patients using semaglutide typically start noticing results after a few weeks of treatment.
How do I know if I am eligible for these weight loss medications?
Eligibility for weight loss medications depends on factors such as your BMI, medical history, and the presence of weight-related health conditions. A consultation with a healthcare provider will determine the best treatment plan for you.
What lifestyle changes should accompany these medications for best results?
For optimal results, these medications should be used in conjunction with a healthy diet, regular physical activity, and behavioral changes. These lifestyle adjustments help sustain weight loss and improve overall health.
How long will I need to take these medications?
The duration of treatment varies based on individual goals and response to the medication. Some patients may need to continue the medication long-term to maintain weight loss and manage appetite.
Are there any common side effects associated with these medications?
Common side effects of GLP-1 receptor agonists (like Semaglutide and Liraglutide and Tirzepatide) include nausea, vomiting, diarrhea, and constipation. These side effects often decrease over time as your body adjusts to the medication.
Can I use Metformin in combination with other weight loss medications?
Metformin may be safely combined with other weight loss medications such as GLP-1 receptor agonists. Your doctor will create a tailored plan that may include metformin based on your health needs to maximize the effectiveness of your weight loss regimen.
What are the benefits of using Metformin for weight loss?
Metformin is primarily used to treat type 2 diabetes but has been found to aid in weight loss by improving insulin sensitivity and reducing appetite. It is often prescribed as part of a weight loss program, especially for individuals with insulin resistance.
How does Tirzepatide work for weight loss?
Tirzepatide is a dual GLP-1 and GIP receptor agonist. It mimics hormones involved in appetite regulation and glucose metabolism, leading to substantial weight loss when combined with a healthy diet and exercise.
What is Semaglutide and how does it help with weight loss?
Semaglutide is a GLP-1 receptor agonist that may help regulate appetite and food intake. It is administered as a weekly injection and may assist with significant weight loss.
诊所简介
Slim Weight Loss Clinic in Palm Beach Gardens, FL offers telehealth medical weight loss with semaglutide, tirzepatide, and liraglutide under MD, FACS supervi...
Slim Weight Loss Clinic operates as a telehealth-focused medical weight loss practice serving patients throughout Florida from its Palm Beach Gardens base. Under the direction of a board-certified surgeon holding MD and FACS credentials, the clinic specializes in pharmacotherapy-driven obesity treatment and chronic weight management using FDA-approved GLP-1 receptor agonists. The practice model centers on remote consultations that provide patients access to prescription weight loss medications without requiring in-person office visits, addressing a significant barrier for individuals managing demanding schedules or mobility limitations.
The clinic’s treatment protocol incorporates three specific GLP-1 medications: liraglutide (originally developed for type 2 diabetes management and approved for weight management at higher doses), semaglutide (available in weekly injection form and shown in clinical trials to produce average weight reduction of 15-20% of body weight), and tirzepatide (a dual GIP/GLP-1 receptor agonist demonstrating superior weight loss outcomes in head-to-head studies). Each medication works through distinct mechanisms affecting appetite regulation, gastric emptying, and insulin sensitivity. The prescribing physician evaluates patient medical history, current medications, contraindications, and weight loss goals to determine appropriate pharmacotherapy. Patients with a history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease require alternative approaches, as these medications carry specific contraindications.
The lead provider’s FACS designation indicates completion of rigorous surgical training and board certification through the American College of Surgeons, bringing a clinical perspective informed by experience treating obesity-related comorbidities and metabolic complications. This surgical background provides context for understanding when pharmacological intervention serves as appropriate primary treatment versus adjunct therapy. The telehealth consultation process includes comprehensive metabolic assessment, review of previous weight loss attempts, evaluation of eating patterns and physical activity levels, and discussion of realistic outcome expectations. Patients receive education on injection technique for subcutaneous administration, recognition of common side effects including nausea and gastrointestinal discomfort, and protocols for dose titration to minimize adverse reactions while optimizing therapeutic effect.
Slim Weight Loss Clinic partners with a compounding or retail pharmacy network to fulfill prescriptions, streamlining the process from consultation to medication delivery. Patients typically begin with conservative dosing—liraglutide at 0.6 mg daily, semaglutide at 0.25 mg weekly, or tirzepatide at 2.5 mg weekly—with gradual increases based on tolerance and response. The clinic monitors patient progress through follow-up telehealth appointments, adjusting treatment plans when weight loss plateaus or side effects become problematic. This ongoing management distinguishes medical weight loss from unsupervised use of these medications, ensuring appropriate clinical oversight as patients navigate the 12-24 month treatment timeline typically required for substantial, sustained weight reduction.
For Palm Beach Gardens residents and Florida patients seeking medical weight loss intervention without the traditional clinic visit model, Slim Weight Loss Clinic offers a streamlined alternative focused specifically on GLP-1 pharmacotherapy. The practice does not provide surgical weight loss options, behavioral therapy programs, or meal replacement products—maintaining a narrow focus on prescription medication management. This specialization allows for efficient telehealth consultations and clear treatment protocols. Patients should expect monthly or quarterly follow-up appointments, prescription refills coordinated through the pharmacy partner, and access to the prescribing physician for questions regarding side effects or dosing adjustments. The clinic serves adults with BMI over 30, or over 27 with weight-related comorbidities such as hypertension, dyslipidemia, or prediabetes, aligning with FDA labeling for these medications in the weight management indication.